$290 Million is the total value of Krensavage Asset Management, LLC's 13 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 30.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REGN | Sell | REGENERON PHARMACEUTICALS | $46,710,000 | +7.1% | 66,880 | -3.2% | 16.10% | +6.4% |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $39,066,000 | -7.4% | 548,828 | -2.7% | 13.46% | -8.0% |
| MCK | Sell | MCKESSON CORP | $38,011,000 | -2.2% | 124,165 | -20.6% | 13.10% | -2.9% |
| ALKS | Sell | ALKERMES PLC | $37,471,000 | +11.6% | 1,424,204 | -1.3% | 12.92% | +10.9% |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $36,171,000 | -18.3% | 201,612 | -1.6% | 12.47% | -18.8% |
| EXEL | Sell | EXELIXIS INC | $34,694,000 | +21.9% | 1,530,406 | -1.7% | 11.96% | +21.1% |
| TARO | Buy | TARO PHARMACEUTICAL INDUS | $24,483,000 | -9.3% | 565,951 | +5.0% | 8.44% | -9.9% |
| BIIB | Buy | BIOGEN INC | $23,451,000 | -5.1% | 111,353 | +8.1% | 8.08% | -5.7% |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $5,681,000 | +4.8% | 114,787 | +7.8% | 1.96% | +4.1% |
| KOD | New | KODIAK SCIENCES INC | $3,479,000 | – | 450,600 | +100.0% | 1.20% | – |
| CAH | New | CARDINAL HEALTH INC | $748,000 | – | 13,200 | +100.0% | 0.26% | – |
| NXTC | Sell | NEXTCURE INC | $149,000 | -19.9% | 30,591 | -1.4% | 0.05% | -21.5% |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $21,000 | – | 10,100 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.